Welcome, Guest
Username: Password: Remember me

TOPIC: Merck Announces Findings for Investigational Triple-ComMK-3682B

Merck Announces Findings for Investigational Triple-ComMK-3682B 3 years 1 month ago #22698

  • Hieupham
  • Hieupham's Avatar
  • Offline
  • Administrator
  • Posts: 59
  • Thank you received: 257
  • Karma: 9
Phase 2 Data Presentations at The Liver Meeting ® Detail SVR12 Rates from Two Studies as Well as SVR8 Rates in Patients for Whom Direct-Acting Antiviral Treatment Previously Failed

hepatitisc.hcvadvocate.org/2016/11/merck...1-2-3-infection.html
Nishkama Karma
Cùng nhau loại bỏ Viêm gan C trên khắp thế giới!
The administrator has disabled public write access.
The following user(s) said Thank You: J. Eugene
Time to create page: 0.119 seconds

Copyright © 2015-2019 FixHepC

Back to Top